Theramex And Enzene Continue Alliance With Deal For RoActemra Rival

Companies Aim To Commercialize Tocilizumab In Europe, UK, Switzerland And Australia

2026
Theramex and Enzene plan to commercialize tocilizumab from 2026 • Source: Alamy

More from Biosimilars

More from Products